AzPA Pharmacy Flash

• FDA Approves First Generics of Xarelto
  The FDA has approved the first generics of Xarelto 2.5 mg tablets, an anticoagulant used to prevent deep vein thrombosis in adults with peripheral artery disease and reduce the risk of major cardiovascular events in adults with coronary artery disease.
• ASRA Pain Medicine: Evidence-Based Risk Reduction for Surgical Site Infections
  ASRA Pain Medicine has updated its guidelines on controlling surgical site infections in procedures, regional anesthesia and pain medicine, addressing risks associated with various pain management approaches.
• FDA Approves Label Changes for Buprenorphine ER Injection
  The FDA has approved label changes for buprenorphine extended-release injection, including a rapid initiation protocol and alternative injection sites. These changes benefit patients and health care providers by reducing obstacles to treatment induction.